3rd International Conference on Immunity, Immunology and Immunochemistry

Mar 07-08, 2022

|

London, United Kingdom



Welcome Message
“As we all know the Coronavirus disease 2019 (COVID-19) pandemic, brought about by extreme intense respiratory disorder Coronavirus 2 (SARS-CoV-2) has influenced a huge number of individuals around the world, touching off an unprecedented effort from mainstream researchers to comprehend the organic supporting of COVID19 pathophysiology. The immune system ensures against infections and sicknesses and produces antibodies to kill microbes.”

                                                                                                             

We’re delighted to welcome you to the 3rd International Conference on Immunity and Immunochemistry, taking place on March 7-8, 2022 in London, UK. This event takes place over 2 days and will comprise plenary lectures, parallel sessions, poster sessions, and our ever-popular ‘Workshop’ events, with something to suit all immunological and vaccines research. 

 

 About the Conference
Immunochemistry 2022 gives a profound impulse into the most recent discoveries and innovative headway in the field of Immunity and Immunochemistry. With individuals from around the globe focused in on finding out about Immunology and its advances; this is your best opportunity to arrive at the biggest array of members from the Immunology community. Widely acclaimed speakers, the latest   strategies, advancements, and the most up to date refreshes in Immunology are signs of this gathering.

 

The aim of the event is to host shows from far-famed specialists across the planet to harness the new collaborations in medical specialty, and medical specialty Sciences. Therefore, researchers within the relevant field will gift their analysis to debate the new results. rising sessions includes, young researchers forum and poster sessions providing likelihood to young participants to develop their career. Through the oral and poster displays, scientific sessions, and networking sessions, we tend to encourage dialogue between all the attendees to fill within the gaps to inspire innovative collaborations. 
 

Target Audience

  • Immunologists, Virologists, Microbiologists

  • Allergists, Pathologists, Biotechnologists

  • Physicians and Infectious diseases treatment doctors

  • University Professors

  • Research Labs

  • Various Societies Members

  • Research Scholars and Medical Students

  • Business Entrepreneurs

  • Manufacturing Medical Devices and Pharma Companies

  • Laboratory Technicians

Why to attend?

The attendees will notice exclusive sessions and panel discussions on the most recent innovations in Molecular medical specialty & Immunogenetics, be the first to showcase your analysis, innovation.

  • Lectures from noted speakers

  • Keynote forums by outstanding Professors and Directors

  • Open Innovation Challenges

  • Certification

  • Poster displays by Young Researchers

  • Global Networking sessions with 50+ Countries

  • Strengthening the network between the university, hospitals, research labs and pharma industries.

  • Summarize the studies of Immune System and targeting therapies to prevent coronavirus disease.

  • Discussing the latest findings and achievements in the treatment of Covid-19 through immunotherapies.

Market Scenario

Global Immune Health Supplements Market was valued at US$ 14.1 Bn in 2019 and is expected to reach US$ 24.7 Bn by 2027, at a CAGR of 7.26% during a forecast period. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market; same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The global immune health supplements market is driven by the increased awareness regarding the benefits of the immune health supplements among consumers. Increasing consumption of immune health supplements around the globe, which is anticipated to drive the immune health supplements market growth in the forecast period. The rise in chronic diseases around the globe, which is influencing the demand for immune health supplements. In addition, rising demand for the immune health supplements coupled with changing lifestyles of consumers across global, which is also estimated to fuel the global immune health supplements market growth in a positive way. Increased investments in R&D are driving the global immune health supplements market growth in a positive way. However, lack of awareness regarding immune health supplements among consumers is expected to hamper the global immune health supplements market growth in the forecast period.

COVID-19 Impact on Vaccines & Drugs Market - Global Forecast to 2025

The global COVID-19 vaccines market is projected to reach USD 1,401 million by 2025 from USD 2,273 million in 2022, at a CAGR of -14.9% during the forecast period. The growth of the COVID vaccines market is attributed majorly to the rising number of people infected with COVID-19 and increasing funding for vaccine development.

On the other hand, the global COVID-19 drugs market is projected to reach USD 2 million by 2025 from USD 165 million in 2020, at a CAGR of -57.8% during the forecast period. The growth of the COVID drugs market is primarily attributed to use of repurposed drugs for compassionate use, and the emergence of alternative therapies such as convalescent plasma therapy which were earlier used for treating epidemic diseases such as SARS, MERS, and H1N1. Moreover, collaborations between global organizations and governments of various nations to promote the supply of essential drugs and medical supplies are fueling the market growth.

Currently, the R&D landscape for COVID-19 vaccines includes 115 vaccine candidates. The most advanced candidates that have recently moved into clinical development are:

  • mRNA-1273 from Moderna

  • Ad5-nCoV from CanSino Biologics

  • INO-4800 from Inovio

  • LV-SMENP-DC and pathogen-specific aAPC from Shenzhen Geno-Immune Medical Institute

Vaccine manufacturing ramp-up to drive the growth further
 

Currently, around 155 molecules are under clinical investigation, and about 45 molecules are under preclinical development to be targeted against COVID-19. In this list, four promising drugs have been repurposed for use against COVID-19.

Remdesivir
Chloroquine and hydroxychloroquine
Lopinavir and ritonavir (and that same combination plus interferon-beta)
An immune system messenger that can help stop the multiplication of viruses.

Program Overview